Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Palmer AJ

Collect these papers and discover other ones on Labmeeting. Learn more.

The polyamine transport system as a target for anticancer drug development.

+ cite this

+ View Abstract

Palmer AJ and Wallace HM

Amino acids 38(2):415-22, 2010 Feb - Who cited this? | PubMed ID: 19956998 | Fulltext

Two-Year Body Composition Analyses of Long-Lived GHR Null Mice.

+ cite this

+ View Abstract

Berryman DE, List EO, Palmer AJ, Chung MY, Wright-Piekarski J, Lubbers E, O'Connor P, Okada S, and Kopchick JJ

The journals of gerontology. Series A, Biological sciences and medical sciences 65(1):31-40, 2010 Jan - Who cited this? | PubMed ID: 19901018 | Fulltext

A putrescine-anthracene conjugate: a paradigm for selective drug delivery.

+ cite this

+ View Abstract

Palmer AJ, Ghani RA, Kaur N, Phanstiel O, and Wallace HM

The Biochemical journal 424(3):431-8, 2009 Dec 15 - Who cited this? | PubMed ID: 19811451 | Fulltext

Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes.

+ cite this

+ View Abstract

List EO, Palmer AJ, Berryman DE, Bower B, Kelder B, and Kopchick JJ

Diabetologia 52(8):1647-55, 2009 Aug - Who cited this? | PubMed ID: 19468705 | Fulltext

A hexapole magnetic guide for neutral atomic beams.

+ cite this

+ View Abstract

Beardmore JP, Palmer AJ, Kuiper KC, and Sang RT

The Review of scientific instruments 80(7):073105, 2009 Jul - Who cited this? | PubMed ID: 19655941 | Fulltext

Age-related changes in body composition of bovine growth hormone transgenic mice.

+ cite this

+ View Abstract

Palmer AJ, Chung MY, List EO, Walker J, Okada S, Kopchick JJ, and Berryman DE

Endocrinology 150(3):1353-60, 2009 Mar - Who cited this? | PubMed ID: 18948397 | Fulltext

Older people and their social spaces: A study of well-being and attachment to place in Aotearoa New Zealand.

+ cite this

+ View Abstract

Wiles JL, Allen RE, Palmer AJ, Hayman KJ, Keeling S, and Kerse N

Social science & medicine (1982) 68(4):664-71, 2009 Feb - Who cited this? | PubMed ID: 19110361 | Fulltext

Long-Term Cost-Effectiveness of Pioglitazone versus Placebo in Addition to Existing Diabetes Treatment: A US Analysis Based on PROactive.

+ cite this

+ View Abstract

Valentine WJ, Tucker D, Palmer AJ, Minshall ME, Foos V, and Silberman C

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 12(1):1-9, 2009 Jan - Who cited this? | PubMed ID: 18657104 | Fulltext

Evaluating the cost-effectiveness of therapy conversion to insulin detemir in patients with type 2 diabetes in germany: a modelling study of long-term clinical and cost outcomes.

+ cite this

+ View Abstract

Valentine WJ, Goodall G, Aagren M, Nielsen S, Palmer AJ, and Erny-Albrecht K

Advances in therapy, 2008 Jun 23 - Who cited this? | PubMed ID: 18568451 | Fulltext

Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naïve type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting.

+ cite this

+ View Abstract

Goodall G, Jendle JH, Valentine WJ, Munro V, Brandt AB, Ray JA, Roze S, Foos V, and Palmer AJ

International journal of clinical practice 62(6):869, 2008 Jun - Who cited this? | PubMed ID: 18479280 | Fulltext

Cost-Effectiveness of Early versus Late Cinacalcet Treatment in Addition to Standard Care for Secondary Renal Hyperparathyroidism in the USA.

+ cite this

+ View Abstract

Ray JA, Borker R, Barber B, Valentine WJ, Belozeroff V, and Palmer AJ

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2008 May 20 - Who cited this? | PubMed ID: 18494747 | Fulltext

Cost-effectiveness of insulin aspart versus human soluble insulin in type 2 diabetes in four European countries: subgroup analyses from the PREDICTIVE study.

+ cite this

+ View Abstract

Palmer JL, Goodall G, Nielsen S, Kotchie RW, Valentine WJ, Palmer AJ, and Roze S

Current medical research and opinion 24(5):1417-28, 2008 May - Who cited this? | PubMed ID: 18400145 | Fulltext

Cost-effectiveness of Intensified versus conventional multifactorial intervention in type 2 diabetes: Results and projections from the steno-2 study.

+ cite this

+ View Abstract

Gæde P, Valentine WJ, Palmer AJ, Tucker DM, Lammert M, Parving HH, and Pedersen O

Diabetes care, 2008 Apr 28 - Who cited this? | PubMed ID: 18443195 | Fulltext

[Health economic consequences of insulin analogues in the treatment of type 1 diabetes in Denmark].

+ cite this

+ View Abstract

Palmer AJ, Lammert M, and Hermansen K

Ugeskrift for laeger 170(15):1250, 2008 Apr 7 - Who cited this? | PubMed ID: 18433583 | Fulltext

A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.

+ cite this

+ View Abstract

Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, Bregman B, and Rodby RA

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 23(4):1216, 2008 Apr - Who cited this? | PubMed ID: 18359872 | Fulltext

Cost-effectiveness analysis of thiazolidinediones in uncontrolled type 2 diabetic patients receiving sulfonylureas and metformin in Thailand.

+ cite this

+ View Abstract

Chirakup S, Chaiyakunapruk N, Chaikledkeaw U, Pongcharoensuk P, Ongphiphadhanakul B, Roze S, Valentine WJ, and Palmer AJ

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 11 Suppl 1:S43-51, 2008 Mar - Who cited this? | PubMed ID: 18387067 | Fulltext

Estimating the long-term cost-effectiveness of exenatide in the United States: an adjunctive treatment for type 2 diabetes mellitus.

+ cite this

+ View Abstract

Minshall ME, Oglesby AK, Wintle ME, Valentine WJ, Roze S, and Palmer AJ

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 11(1):22-33, 2008 - Who cited this? | PubMed ID: 18237357 | Fulltext

An Asian regional analysis of cost-effectiveness of early irbesartan treatment versus conventional antihypertensive, late amlodipine, and late irbesartan treatments in patients with type 2 diabetes, hypertension, and nephropathy.

+ cite this

+ View Abstract

Annemans L, Demarteau N, Hu S, Lee TJ, Morad Z, Supaporn T, Yang WC, and Palmer AJ

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 11(3):354-64, 2008 - Who cited this? | PubMed ID: 17888064 | Fulltext

Cost utility analysis of cinacalcet in addition to standard of care in the UK.

+ cite this

Ray JA, Valentine WJ, and Palmer AJ

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 22(11):3355-7, 2007 Nov - Who cited this? | PubMed ID: 17785347 | Fulltext

Cost-effectiveness of diabetes case management for low-income populations.

+ cite this

+ View Abstract

Gilmer TP, Roze S, Valentine WJ, Emy-Albrecht K, Ray JA, Cobden D, Nicklasson L, Philis-Tsimikas A, and Palmer AJ

Health services research 42(5):1943-59, 2007 Oct - Who cited this? | PubMed ID: 17850527 | Fulltext

Irbesartan treatment of patients with type 2 diabetes, hypertension and renal disease: a UK health economics analysis.

+ cite this

+ View Abstract

Palmer AJ, Valentine WJ, and Ray JA

International journal of clinical practice 61(10):1626-33, 2007 Oct - Who cited this? | PubMed ID: 17877649 | Fulltext

PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.

+ cite this

+ View Abstract

Valentine WJ, Bottomley JM, Palmer AJ, Brändle M, Foos V, Williams R, Dormandy JA, Yates J, Tan MH, Massi-Benedetti M, and PROactive Study Group

Diabetic medicine : a journal of the British Diabetic Association 24(9):982-1002, 2007 Sep - Who cited this? | PubMed ID: 17593245 | Fulltext

Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis.

+ cite this

+ View Abstract

Palmer AJ, Valentine WJ, Ray JA, Roze S, and Muszbek N

The European journal of health economics : HEPAC : health economics in prevention and care 8(2):161-8, 2007 Jun - Who cited this? | PubMed ID: 17237927 | Fulltext

Analysis of mouse skin reveals proteins that are altered in a diet-induced diabetic state: a new method for detection of type 2 diabetes.

+ cite this

+ View Abstract

List EO, Berryman DE, Palmer AJ, Qiu L, Sankaran S, Kohn DT, Kelder B, Okada S, and Kopchick JJ

Proteomics 7(7):1140-9, 2007 Apr - Who cited this? | PubMed ID: 17390296 | Fulltext

An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK.

+ cite this

+ View Abstract

Palmer AJ, Valentine WJ, Ray JA, Foos V, Lurati F, Smith I, Lammert M, and Roze S

Current medical research and opinion 23(4):895-901, 2007 Apr - Who cited this? | PubMed ID: 17407646 | Fulltext

Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes.

+ cite this

+ View Abstract

Ray JA, Boye KS, Yurgin N, Valentine WJ, Roze S, McKendrick J, Tucker DM, Foos V, and Palmer AJ

Current medical research and opinion 23(3):609-22, 2007 Mar - Who cited this? | PubMed ID: 17355742 | Fulltext

Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US.

+ cite this

+ View Abstract

Ray JA, Valentine WJ, Roze S, Nicklasson L, Cobden D, Raskin P, Garber A, and Palmer AJ

Diabetes, obesity & metabolism 9(1):103-13, 2007 Jan - Who cited this? | PubMed ID: 17199725 | Fulltext

Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: a modeling study of cost-effectiveness in the United States.

+ cite this

+ View Abstract

Valentine WJ, Erny-Albrecht KM, Ray JA, Roze S, Cobden D, and Palmer AJ

Advances in therapy 24(2):273-90, 2007 - Who cited this? | PubMed ID: 17565917 | Fulltext

Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.

+ cite this

+ View Abstract

Cohen N, Minshall ME, Sharon-Nash L, Zakrzewska K, Valentine WJ, and Palmer AJ

PharmacoEconomics 25(10):881-97, 2007 - Who cited this? | PubMed ID: 17887808 | Fulltext

Discovery and uses of pegvisomant: a growth hormone antagonist.

+ cite this

+ View Abstract

Berryman DE, Palmer AJ, Gosney ES, Swaminathan S, DeSantis D, and Kopchick JJ

Endokrynologia Polska 58(4):322-9, 2007 - Who cited this? | PubMed ID: 18058724 | Fulltext

A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension.

+ cite this

+ View Abstract

Palmer AJ, Valentine WJ, Tucker DM, Ray JA, Roze S, Annemans L, Lapuerta P, Chen R, Gabriel S, Carita P, Rodby RA, de Zeeuw D, Parving HH, and Laville M

Current medical research and opinion 22(11):2095-100, 2006 Nov - Who cited this? | PubMed ID: 17076969 | Fulltext

Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: a modelling study of HbA1c targets.

+ cite this

+ View Abstract

Valentine WJ, Palmer AJ, Nicklasson L, Cobden D, and Roze S

International journal of clinical practice 60(9):1138-45, 2006 Sep - Who cited this? | PubMed ID: 16939559 | Fulltext

[Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy].

+ cite this

+ View Abstract

Palmer AJ, Roze S, Rodby RA, Valentine WJ, Ritz E, and Lehnert H

Deutsche medizinische Wochenschrift (1946) 131(31-32):1721-6, 2006 Aug 4 - Who cited this? | PubMed ID: 16868875 | Fulltext

Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analysis in a German setting.

+ cite this

+ View Abstract

Roze S, Valentine WJ, Evers T, and Palmer AJ

Current medical research and opinion 22(7):1415-24, 2006 Jul - Who cited this? | PubMed ID: 16834840 | Fulltext

Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men?.

+ cite this

+ View Abstract

Antikainen RL, Grodzicki T, Palmer AJ, Beevers DG, Webster J, Bulpitt CJ, and Department of Health and Social Security Hypertension Care Computer Project (DHCCP)

Journal of human hypertension 20(6):451-9, 2006 Jun - Who cited this? | PubMed ID: 16708082 | Fulltext

Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patients with type 2 diabetes, hypertension, and renal disease in Switzerland.

+ cite this

+ View Abstract

Palmer AJ, Roze S, Valentine WJ, Ray JA, Frei A, Burnier M, Hess B, Spinas GA, and Brändle M

Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 136(21-22):346-52, 2006 May 27 - Who cited this? | PubMed ID: 16779715 | Fulltext

Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes.

+ cite this

+ View Abstract

Palmer AJ, Dinneen S, Gavin JR, Gray A, Herman WH, and Karter AJ

Current medical research and opinion 22(5):861-72, 2006 May - Who cited this? | PubMed ID: 16709308 | Fulltext

Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting.

+ cite this

Currie CJ, McEwan P, Poole C, Valentine WJ, Palmer AJ, Lammert M, Nicklasson L, Foos V, and Roze S

Current medical research and opinion 22(5):967-9; author reply 968-9, 2006 May - Who cited this? | PubMed ID: 16709318 | Fulltext

[Health economic consequences of the use of irbesartan in patients with type 2 diabetes, hypertension and nephropathy in Switzerland].

+ cite this

+ View Abstract

Frei A, Palmer AJ, Burnier M, and Hess B

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis 95(11):401-8, 2006 Mar 15 - Who cited this? | PubMed ID: 16570646 | Fulltext

Counting the costs of overweight and obesity: modeling clinical and cost outcomes.

+ cite this

+ View Abstract

Tucker DM, Palmer AJ, Valentine WJ, Roze S, and Ray JA

Current medical research and opinion 22(3):575-86, 2006 Mar - Who cited this? | PubMed ID: 16574040 | Fulltext

Cost-consequence analysis in a French setting of screening and optimal treatment of nephropathy in hypertensive patients with type 2 diabetes.

+ cite this

+ View Abstract

Palmer AJ, Chen R, Valentine WJ, Roze S, Bregman B, Mehin N, and Gabriel S

Diabetes & metabolism 32(1):69-76, 2006 Feb - Who cited this? | PubMed ID: 16523189 | Fulltext

Cost-effectiveness of basal insulin from a US health system perspective: comparative analyses of detemir, glargine, and NPH.

+ cite this

+ View Abstract

Valentine WJ, Palmer AJ, Erny-Albrecht KM, Ray JA, Cobden D, Foos V, Lurati FM, and Roze S

Advances in therapy 23(2):191-207, 2006 - Who cited this? | PubMed ID: 16751153 | Fulltext

Modelling lifetime metabolic progression and cost effectiveness of treatment strategies for type 2 diabetes.

+ cite this

Palmer AJ and Currie CJ

PharmacoEconomics 24(9):927-9; author reply 929-35, 2006 - Who cited this? | PubMed ID: 16942126 | Fulltext

Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting.

+ cite this

+ View Abstract

Valentine WJ, Palmer AJ, Lammert M, Nicklasson L, Foos V, and Roze S

Current medical research and opinion 21(12):2063-71, 2005 Dec - Who cited this? | PubMed ID: 16368057 | Fulltext

Insulin pumps: more consultation was needed.

+ cite this

Palmer AJ, Tucker DM, Ray JA, Valentine WJ, Currie C, McEwan P, and Brändle M

BMJ (Clinical research ed.) 331(7521):905-6, 2005 Oct 15 - Who cited this? | PubMed ID: 16223833 | Fulltext

Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain.

+ cite this

+ View Abstract

Ray JA, Valentine WJ, Secnik K, Oglesby AK, Cordony A, Gordois A, Davey P, and Palmer AJ

Current medical research and opinion 21(10):1617-29, 2005 Oct - Who cited this? | PubMed ID: 16238902 | Fulltext

Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.

+ cite this

+ View Abstract

Roze S, Valentine WJ, Zakrzewska KE, and Palmer AJ

Diabetic medicine : a journal of the British Diabetic Association 22(9):1239-45, 2005 Sep - Who cited this? | PubMed ID: 16108855 | Fulltext

Health economics--what the nephrologist should know.

+ cite this

Palmer AJ

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20(6):1038-41, 2005 Jun - Who cited this? | PubMed ID: 15840678 | Fulltext

Cost-effectiveness of irbesartan in diabetic nephropathy: a systematic review of published studies.

+ cite this

+ View Abstract

Palmer AJ, Tucker DM, Valentine WJ, Roze S, Gabriel S, and Cordonnier DJ

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20(6):1103-9, 2005 Jun - Who cited this? | PubMed ID: 15855214 | Fulltext

Treating diabetes to accepted standards of care: a 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States.

+ cite this

+ View Abstract

Minshall ME, Roze S, Palmer AJ, Valentine WJ, Foos V, Ray J, and Graham C

Clinical therapeutics 27(6):940-50, 2005 Jun - Who cited this? | PubMed ID: 16117994 | Fulltext

Search Google Scholar for Palmer AJ

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.